Schedule 13G Filing by Iroquois Capital Management LLC and Others for Bionano Genomics, Inc.

Iroquois Capital Management LLC, Richard Abbe, and Kimberly Page have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of shares in Bionano Genomics, Inc. The filing indicates that Iroquois Capital Management LLC owns 3.8% of the company's common stock, Richard Abbe owns 5.4%, and Kimberly Page owns 3.8%. The shares reported do not include warrants held by Iroquois Master Fund Ltd. and Iroquois Capital Investment Group LLC, which are subject to 4.99% Beneficial Ownership Blockers, preventing their exercise. The filing is made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.